Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs and FX are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs and FX are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
AskTraders may earn a commission when you click through to a broker.
Smith+Nephew Cuts Guidance, Ends J&J Talks
Smith+Nephew has lowered its full-year profit outlook on weak US hip and knee sales and confirmed that talks with Johnson & Johnson about its Orthopaedics business have ended, leaving the board still exploring options.
Smith+Nephew (LSE: SN), a FTSE 100 constituent, has cut its full-year guidance, with trading profit growth now expected at around 4% rather than around 8%. It blamed the outlook for US hip and knee implants in the fourth quarter.
Underlying revenue growth is now seen at around 3%, down from around 4%. Trading profit is forecast at around $1.25bn rather than $1.3bn, and free cash flow at around $750m rather than $800m.
SN.LSE
We have revised our full-year guidance to reflect the slower growth in US Orthopaedics, which we expect to continue through the fourth quarter. Despite this, we remain confident in delivering profit growth ahead of revenue growth, together with strong free cash flow and cash conversion.
Deepak Nath, chief executive of Smith+Nephew
Third-quarter revenue, for the quarter ended 26 September, rose to $1,551m from $1,501m a year earlier, up 3.4% on an underlying basis and faster than in the second quarter.
Sponsored content
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sports Medicine & ENT led with $507m, up 7.9%, helped by 11.2% growth in Joint Repair. Advanced Wound Management slipped 0.2% to $454m, as Bioactives fell 8.8% after changes to skin substitute reimbursement at the start of 2026. The company said the market was adapting more slowly than it had anticipated.
Smith+Nephew Q3 2026 underlying revenue growth by business unit, quarter ended 26 September versus Q3 2025. Source: Smith+Nephew.
Orthopaedics grew 2.5% to $590m, but US knee implants fell 7.3% and US hips 1.0%. The company cited business lost in earlier periods, market softness and a shift to cementless knees, and said hip sales were held back by the pace of deploying its CATALYSTEM hip system. Outside the US, knees rose 4.0% and hips 6.0%.
The company also responded to press comment about a possible combination of its Orthopaedics business with the DePuy Synthes unit of Johnson & Johnson (NYSE: JNJ). It confirmed it approached J&J earlier this year and that discussions took place, but said they have now ended. The board has considered strategic options for Orthopaedics for some months and will keep exploring them.
Sponsored
A $500m share buyback announced on 6 May is half done, with $250m completed by the end of the quarter. An analyst call is due at midday today, and full-year results follow on 1 March.
The AskTraders Analyst Team features experts in technical and fundamental analysis, as well as traders specializing in stocks, forex, and cryptocurrency.
Stay ahead of the markets
Sign up to our free Morning Markets email, every weekday before the open.
Stay ahead of the markets
Morning Markets
Weekdays
FTSE, overnight moves and what matters before the open.
Show personalised advertising and content, and measure how adverts and content perform
Learn about our audience and develop and improve our services
Learn more
Advertising pays for our free market news, analysis and trading tools.
If you accept, we and our partners may also match and combine data from other sources, link your devices, and identify your device from its characteristics, precise location or by actively scanning it. Some partners rely on legitimate interest rather than consent for certain purposes; you can object in the full list.
You can reject, or choose which purposes to allow under Manage options. Your choice is kept for this browser and you can change it at any time. See every purpose and partner
Necessary
Always active
Needed to run AskTraders and to remember your choice here. Always on.
Preferences
Remembers choices you make on AskTraders, such as display settings.
Analytics
Lets us count visits and see which pages are useful, using tools such as Google Analytics.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Advertising and personalisation
Lets us and our advertising partners show personalised adverts and content, measure them and learn about our audience, and lets us offer web push notifications. See every purpose and partner
We and our advertising partners use cookies to show relevant advertising and measure its performance. You can opt out of the sale or sharing of your personal information, and of personalised advertising, at any time using the link below.
Necessary
Always active
Needed to run AskTraders and to remember your choice here. Always on.
Preferences
Remembers choices you make on AskTraders, such as display settings.
Analytics
Lets us count visits and see which pages are useful, using tools such as Google Analytics.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Advertising and personalisation
Lets us and our advertising partners show personalised adverts and content, measure them and learn about our audience, and lets us offer web push notifications. See every purpose and partner
